An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to ...
People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of ...
Faced with an anxious patient convinced she is destined to suffer the same fate as her father, who died of a heart attack, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results